CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
出版年份 2014 全文链接
标题
CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
作者
关键词
CXCR4, AMD3100, Tumor cell mobilization, Radiosensitivity
出版物
CLINICAL & EXPERIMENTAL METASTASIS
Volume 31, Issue 7, Pages 829-839
出版商
Springer Nature
发表日期
2014-08-25
DOI
10.1007/s10585-014-9673-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer
- (2015) Colin D. Weekes et al. NEOPLASIA
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer
- (2014) M. D. Galsky et al. CLINICAL CANCER RESEARCH
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
- (2012) W. Zhuo et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Emerging Pathways Mediating Growth, Invasion, and Metastasis of Tumors Progressing in an Irradiated Microenvironment
- (2012) F. Kuonen et al. CLINICAL CANCER RESEARCH
- CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein
- (2012) Owen J. McGinn et al. JOURNAL OF CELL SCIENCE
- Neovascularization After Irradiation: What is the Source of Newly Formed Vessels in Recurring Tumors?
- (2012) S. V. Kozin et al. JNCI-Journal of the National Cancer Institute
- Microenvironment and Radiation Therapy
- (2012) Michio Yoshimura et al. Biomed Research International
- Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging
- (2011) Alessio Giubellino et al. CANCER LETTERS
- Combined Blockade of Integrin- 4 1 Plus Cytokines SDF-1 or IL-1 Potently Inhibits Tumor Inflammation and Growth
- (2011) M. C. Schmid et al. CANCER RESEARCH
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
- (2011) M P Rettig et al. LEUKEMIA
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
- (2010) S. V. Kozin et al. CANCER RESEARCH
- Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases
- (2010) Daisuke Uchida et al. EUROPEAN JOURNAL OF CANCER
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
- (2009) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+cell to Imatinib and Nilotinib
- (2009) Falk Dillmann et al. LEUKEMIA & LYMPHOMA
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started